Material for use in a magnetic resonance system, method for producing the material and magnetic resonance system

US9645208B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9645208-B2
Application numberUS-201313848132-A
CountryUS
Kind codeB2
Filing dateMar 21, 2013
Priority dateMar 22, 2012
Publication dateMay 9, 2017
Grant dateMay 9, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A material for use in a magnetic resonance system includes a carrier material and a doping material. The carrier material and the doping material are admixed in a specific proportion. A volume of the material smaller than 1 mm 2 contains a substantially homogeneous intermixing of the carrier material and the doping material.

First claim

Opening claim text (preview).

The invention claimed is: 1. A material for use in a magnetic resonance system, the material comprising: a carrier materials; and a magnetic doping material which is admixed in a specific proportion with the carrier material for producing the material for use in the magnetic resonance system, wherein a volume of the material which is smaller than 1 mm 3 contains a substantially homogeneous intermixing of the carrier material and the doping material, and wherein the material has a T2* relaxation time of nuclear spins in the volume which is reduced by a factor of at least 2 compared to a corresponding T2* relaxation time of the carrier material. 2. The material as claimed in claim 1 , wherein a particle size of the doping material is smaller than approximately 200 μm. 3. The material as claimed in claim 2 , wherein the particle size of the doping material is smaller than approximately 10 μm. 4. The material as claimed in claim 1 , wherein the doping material comprises magnetic nanoparticles and wherein a particle size of the doping material is smaller than approximately 1 μm. 5. The material as claimed in claim 4 , wherein the particle size of the doping material is smaller than approximately 100 nm. 6. The material as claimed in claim 4 , wherein the magnetic nanoparticles are ferromagnetic. 7. The material as claimed in claim 1 , wherein the proportion of the magnetic doping material admixed in the carrier material is in the range of 0.1%-80% by weight or volume. 8. The material as claimed in claim 7 , wherein the proportion of the magnetic doping material admixed in the carrier material is in the range of 1%-20% by weight or volume. 9. The material as claimed in claim 1 , wherein the carrier material is an acrylonitrile butadiene styrene (ABS) plastic. 10. The material as claimed in claim 1 , wherein the carrier material is selected from the group consisting of: thermoplastics, thermoplastic elastomers, elastomers, thermosets, foams. 11. The material as claimed in claim 1 , wherein the doping material is selected from a first group of diamagnetic materials consisting of the elements: graphite, bismuth; or from a second group of paramagnetic materials consisting of the elements: platinum, chromium, tungsten, ferritin. 12. The material as claimed in claim 1 , wherein the material has a macroscopic magnetic susceptibility which is substantially equal to a susceptibility of water or tissue or organic material or air. 13. The material as claimed in claim 1 , wherein the material has a macroscopic magnetic susceptibility which is unequal to at least a susceptibility of water and tissue and organic material and air. 14. The material as claimed in claim 1 , wherein the factor is 4. 15. The material as claimed in claim 1 , wherein the material comprises a magnetic further doping material which is admixed in a further proportion, wherein the volume contains a homogeneous intermixing of the carrier material and the doping material and the further doping material and wherein a preceding sign of a susceptibility of the further doping material is unequal to a preceding sign of a susceptibility of the doping material. 16. The material as claimed in claim 15 , wherein a particle size of the further doping material is smaller than 100 μm. 17. The material as claimed in claim 15 , wherein the proportion and the further proportion are different so that a macroscopic susceptibility is equal to a specific value. 18. A method for producing a material for use in a magnetic resonance system, the method comprising: melting a carrier material made of plastic via an extruder, and admixing a proportion of a magnetic doping material with the carrier material for producing the material for use in the magnetic resonance system, wherein a volume of the material which is smaller than 1 mm 3 contains a homogeneous intermixing of the carrier material with the doping material, and wherein the material has a T2* relaxation time of nuclear spins in the volume which is reduced by a factor of at least 2 compared to a corresponding T2* relaxation time of the carrier material. 19. A magnetic resonance system with a sensitive range, wherein the magnetic resonance system is set up in order to obtain magnetic resonance data for imaging within the sensitive range, wherein the magnetic resonance system comprises: components for imaging within the sensitive range, wherein the components comprise a material comprising a carrier material and a magnetic doping material which is admixed in a proportion with the carrier material, wherein a volume of the material which is smaller than 1 mm 3 contains a homogeneous intermixing of the carrier material and the doping material, and wherein the material has a T2* relaxation time of nuclear spins in the volume which is reduced by a factor of at least 2 compared to a corresponding T2* relaxation time of the carrier material.

Assignees

Inventors

Classifications

  • G01R33/38Primary

    Systems for generation, homogenisation or stabilisation of the main or gradient magnetic field · CPC title

  • Manufacture of RF coils, e.g. using printed circuit board technology; additional hardware for providing mechanical support to the RF coil assembly or to part thereof, e.g. a support for moving the coil assembly relative to the remainder of the MR system · CPC title

  • by using nuclear magnetic resonance (G01N24/12 takes precedence) · CPC title

  • in a non-magnetic matrix, e.g. granular solids (granular films H01F10/007) · CPC title

  • of organic or organo-metallic materials {, e.g. graphene}(H01F1/44 takes precedence) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9645208B2 cover?
A material for use in a magnetic resonance system includes a carrier material and a doping material. The carrier material and the doping material are admixed in a specific proportion. A volume of the material smaller than 1 mm 2 contains a substantially homogeneous intermixing of the carrier material and the doping material.
Who is the assignee on this patent?
Biber Stephan, Candidus Yvonne, Fischer Hubertus, and 3 more
What technology area does this patent fall under?
Primary CPC classification G01R33/38. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).